The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies

2015 Phenotypic Classification for Primary Immunedefeciencies

Aziz Bousfiha , Leïla Jeddane, Waleed Al-Herz, Fatima AilalAffiliated with
Clinical Immunology Unit, A. Harouchi Hospital, Ibn Roshd Medical School, King Hassan II University
, Jean‐Laurent Casanova, Talal Chatila, Mary Ellen Conley, Charlotte Cunningham‐Rundles, Amos Etzioni Et al., (2015). Journal of Clinical Immunology

Note to self: This is a very extensive article, need a medical encyclopedia ?. Keeping for future reference as I learn more about PIs.

Categories Quick Jump

Quick Jump

Action Alert 🚨 Patient Advocacy NON MEDICAL SWITCHING Support NICA

Action Alert 🚨 Patient Advocacy SUPPORT NICA. Rare Disease treatment is not about taking Ibuprofen, or Naproxen! *We are talking about BIOLOGICS! Support NICA with this Call to Action. Summary: The biological that you infuse should be based upon what your medical professionals and the patient decide which is therapeutically appropriate. Health Care Companies should not force their brand of biologics on the patients.
To send a letter to your elected official and ask them to take action to protect patients in your state today, go to http://www.keepmyrx.org/tx-hb-2882/

Like this:

What do you think? Cancel reply

Sharing is Caring!

Like this:

What do you think? Cancel reply